Anastasiya Quimby, MD
Surgical Oncology · West Palm Beach, FLNPI 1750720116
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,897 of the $2,939 with a category attached, or 64.5%. 17 manufacturers reported payments, led by Axogen at 37.1% of the total. Reporting peaked in 2020 at $1,059 and has fallen 86.2% since, to $146 in 2025.
Across 42 payments — averaging $69.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$1K
- Inspire Medical Systems, Inc.$380
- Kls-martin L.p.$349
- Integra Lifesciences Corporation$250
- Synthes GmbH$250
- Aroa Biosurgery Incorporated$162
- plus $459 from 11 others
What the payments were for
- Speaking & faculty fees$2509%
- Travel & lodging$79227%
- Food & beverage$1,89765%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 5 | $1,090 |
| Inspire Medical Systems, Inc. | 3 | $380 |
| Kls-martin L.p. | 7 | $349 |
| Integra Lifesciences Corporation | 6 | $250 |
| Synthes GmbH | 1 | $250 |
| Aroa Biosurgery Incorporated | 1 | $162 |
| E.r. Squibb & Sons, L.L.C. | 1 | $74 |
| Merck | 4 | $74 |
| Revance Therapeutics, Inc. | 1 | $67 |
| Kerecis Limited | 4 | $62 |
| Johnson & Johnson(2 entities) | 2 | $49 |
| Stryker | 1 | $40 |
| Ambu Inc. | 2 | $28 |
| Acera Surgical, Inc. | 1 | $20 |
| AstraZeneca | 1 | $17 |
| Zimvie Inc. | 1 | $15 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVANCE NERVE GRAFT$1,062
- AxoGuard Nerve Connector$937
- AxoGuard Nerve Protector$937
- Inspire$260
- BILAYER WOUND MATRIX (BWM)$110
- INTEGRA WOUND MATRIX (IWM)$110
- AMNIOEXCEL$110
- IDRT$110
- FLOWABLE$110
How this compares
$2,939 in reported general payments places this provider in the 55th percentile of 133 surgical oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pentoxifylline | 103 | $2,382 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 72 | $886 |
| Nystatin | 21 | $411 |
| Chlorhexidine Gluconate | 32 | $168 |
| Levofloxacin | 18 | $164 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $81 |
| Tramadol Hcl | 15 | $28 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in West Palm Beach
- Neha GoelMiami$200K
- Jonathan ZagerTampa$191K
- Horacio AsbunMiami$161K
- Adrian Legaspi SauterHialeah$116K
- Kenneth MeredithSarasota$113K
- Pamela HodulTampa$94K
- Mehran HabibiMiami$73K
- Paul BloomstonFort Myers$68K
- Kristin RojasMiami$57K
- Douglas ReintgenTarpon Springs$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.